Cargando…

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.

The serum concentration of two pro-angiogenic cytokines: basic fibroblast growth factor (bFGF) and transforming growth factor beta1 (TGF-beta1), and anti-angiogenic factor endostatin in the serum of 80 never treated B-cell chronic lymphocytic leukemia (CLL) patients and 27 healthy volunteers was mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gora-Tybor, Joanna, Blonski, Jerzy Z, Robak, Tadeusz
Formato:	Texto
Lenguaje:	English
Publicado:	2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781611/ https://www.ncbi.nlm.nih.gov/pubmed/12857600 http://dx.doi.org/10.1080/0962935031000134888

Ejemplares similares

Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development
por: Rogalińska, Małgorzata, et al.
Publicado: (2017)

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
por: Robak, T, et al.
Publicado: (1999)

Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study
por: Mikulski, Damian, et al.
Publicado: (2022)

High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.
por: Urbańska-Ryś, Halina, et al.
Publicado: (2003)

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388
por: Góra-Tybor, J., et al.
Publicado: (1995)

Application of New Drugs in Chronic Lymphocytic Leukemia
por: Robak, Tadeusz
Publicado: (2010)

Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin-dependent kinase inhibitors
por: Kubczak, Małgorzata, et al.
Publicado: (2019)

Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
por: Robak, Tadeusz, et al.
Publicado: (2022)

Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (1999)

The Levels of Circulating Proangiogenic Factors in Migraineurs
por: Michalak, Slawomir, et al.
Publicado: (2017)

Atypical Chronic Lymphocytic Leukemia—The Current Status
por: Robak, Tadeusz, et al.
Publicado: (2023)

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-α and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice
por: Warzocha, K., et al.
Publicado: (1994)

Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion
por: Pfister, Marcel, et al.
Publicado: (2013)

Exercise increases endostatin in circulation of healthy volunteers
por: Gu, Jian-Wei, et al.
Publicado: (2004)

Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors
por: Etulain, Julia, et al.
Publicado: (2014)

The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions
por: Robak, Tadeusz, et al.
Publicado: (2022)

Endostatin, an Inhibitor of Angiogenesis, Decreases After Bidirectional Superior Cavopulmonary Anastamosis
por: Field-Ridley, Aida, et al.
Publicado: (2012)

Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
por: Wan, Yun-Yan, et al.
Publicado: (2013)

PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives
por: Hus, Iwona, et al.
Publicado: (2022)

Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients
por: Motta, Marina, et al.
Publicado: (2010)

A Case of Acute Myeloid Leukemia Concurrent With Untreated Chronic Lymphocytic Leukemia
por: Lee, Hye-Young, et al.
Publicado: (2017)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality
por: Rychter, Anna, et al.
Publicado: (2023)

Endostatin in the pancreas
por: Wigmore, S J
Publicado: (2005)

Recombinant Human Endostatin Endostar Suppresses Angiogenesis and Lymphangiogenesis of Malignant Pleural Effusion in Mice
por: Ma, Xingqun, et al.
Publicado: (2012)

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis
por: Yoshida, Junko, et al.
Publicado: (2015)

Spleen Tyrosine Kinase Contributes to Müller Glial Expression of Proangiogenic Cytokines in Diabetes
por: Yerlikaya, Esma I., et al.
Publicado: (2022)

Rapid Progression of Pulmonary Blastomycosis in an Untreated Patient of Chronic Lymphocytic Leukemia
por: Sarkar, Pralay K., et al.
Publicado: (2014)

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
por: Hill, Brian T, et al.
Publicado: (2015)

Blastoschizomyces capitatus pneumonia in a patient with untreated chronic lymphocytic leukemia
por: Trovato, Laura, et al.
Publicado: (2018)

Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
por: Wang, Shan, et al.
Publicado: (2016)

Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020)

Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance
por: Robak, Tadeusz, et al.
Publicado: (2022)

Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage B-Cell Chronic Lymphocytic Leukemia
por: Wołowiec, Dariusz, et al.
Publicado: (2006)

Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
por: Robak, Ewa, et al.
Publicado: (2023)

ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA
por: Varone, Ersilia, et al.
Publicado: (2022)

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)
por: Chanan-Khan, A, et al.
Publicado: (2017)

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006)

An experimental research into endostatin microbubble combined with focused ultrasound for anti-tumor angiogenesis in colon cancer
por: Zhang, Xiufeng, et al.
Publicado: (2014)

The effect of endostatin on angiogenesis and osteogenesis of steroid-induced osteonecrosis of the femoral head in a rabbit model
por: Zhao, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sk4ulsf0ppopc5pnnffvggpmjm